Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination

Dendritic cells and the control of immunity

Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,496

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572

Neoantigens in cancer immunotherapy

Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819

A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

Carreno, B. M., Magrini, V., Becker-Hapak, M., Kaabinejadian, S., Hundal, J., Petti, A. A., Ly, A., Lie, W.-R., Hildebrand, W. H., Mardis, E. R., et al. (2015) · Science · doi:10.1126/science.aaa3828 · Cited by 1,285

CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO

Trombetta, E. S., & Mellman, I. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104538 · Cited by 1,226

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing

Yadav, M., Jhunjhunwala, S., Phung, Q. T., Lupardus, P., Tanguay, J., Bumbaca, S., Franci, C., Cheung, T. K., Fritsche, J., Weinschenk, T., et al. (2014) · Nature · doi:10.1038/nature14001 · Cited by 1,186

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J. S., Gailani, F., Riley, L. B., Conlon, K. C., Pockaj, B. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012863 · Cited by 935

An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants

Huang, L., Zhao, F., He, M., Fang, Y., Ma, X., Lu, S., Li, E., Xiao, H. Q., Zhu, H., Wang, X., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.002 · Cited by 23

Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens

Zhang, S.-W., Wang, H., Ding, X., Xiao, Y.-L., Shao, Z.-M., You, C., Gu, Y., & Jiang, Y. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.03.009 · Cited by 23

Nanoparticles for immunotherapy

Anfray, C., Mainini, F., & Andón, F. T. (2020) · Frontiers of nanoscience · doi:10.1016/b978-0-08-102828-5.00011-5 · Cited by 21

The main battlefield of mRNA vaccine – Tumor immune microenvironment

Li, X., Ma, S., Gao, T., Mai, Y., Song, Z., & Yang, J. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109367 · Cited by 22

DNA-based nanostructures for RNA delivery

Wu, Y., Luo, L., Hao, Z., & Liu, D. (2024) · Medical Review · doi:10.1515/mr-2023-0069 · Cited by 23

Virus‐Mimic mRNA Vaccine for Cancer Treatment

Meng, C., Chen, Z., Mai, J., Shi, Q., Tian, S., Hinkle, L. E., Li, J., Zhang, Z., Ramirez, M., Zhang, L., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100144 · Cited by 21

Emerging lipid–polymer hybrid nanoparticles for genome editing

Gameiro, M. D., Mano, J. F., & Gaspar, V. M. (2024) · Polymer Chemistry · doi:10.1039/d4py00298a · Cited by 22

Ovalbumin-loaded paramagnetic nano-triangles for enhanced dendritic cell stimulation, T1-MR imaging, and antitumor immunity

Hou, Y., Tang, Z., Farheen, J., Saeed, M., Luo, L., Ren, W., Luo, D., Mushtaq, A., Zhao, R., Ge, J., et al. (2023) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2022.11.024 · Cited by 18

mRNA therapeutics for disease therapy: principles, delivery, and clinical translation

Zhou, D., Wang, K., Zhang, Y., Ma, K., Yang, X., Li, Z.-Y., Yu, S., Chen, K., & Qiao, S. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02782h · Cited by 18

mRNA delivery systems 2.0: Engineering extrahepatic delivery for non-vaccine therapeutics

Dalabehera, M., Ghosh, A., Mohanty, S., Chellappan, D. K., Chaudhari, S., Ale, Y., Poonia, N., Subudhi, R. N., Khanna, M., & Lim, H. G. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102584 · Cited by 22

mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes

Ibragimova, A. A., Fedorov, A. A., Kirilenko, K. M., Чойнзонов, Е. Л., Denisov, E. V., & Patysheva, M. R. (2025) · Acta Naturae · doi:10.32607/actanaturae.27707 · Cited by 14

Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review

Belay, W. Y., Nibret, G., & Aschale, Y. (2023) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s418314 · Cited by 16

Broad-spectrum Delta-BA.2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex

Du, P., Huang, L., Fang, Y., Zhao, F., Li, Q., Ma, X., Li, R., Chen, Q., Shen, H., Wang, Q., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012116 · Cited by 13

Rational Design of Polymeric mRNA Delivery Vectors to Achieve Excellent Room-Temperature Storage Stability and Delivery Efficiency

Shi, J., Yin, H., Sun, Q., Teng, R., Zhu, Y., & Du, J. (2024) · Chemistry of Materials · doi:10.1021/acs.chemmater.4c00219 · Cited by 14

Rational design of polymer-based mRNA delivery systems for cancer treatment

Wan, Q., Sun, Y., Sun, X., & Zhou, Z. (2024) · Polymer Chemistry · doi:10.1039/d4py00206g · Cited by 15

Advances in Development of mRNA-Based Therapeutics

Huang, L., Zhang, L., Li, W., Li, S., Wen, J., Li, H., & Liu, Z. (2020) · Current topics in microbiology and immunology · doi:10.1007/82_2020_222 · Cited by 16

Recent Approaches to mRNA Vaccine Delivery By Lipid-Based Vectors Prepared By Continuous-Flow Microfluidic Devices

Toudeshkchouei, M. G., Tavakoli, A., Mohammadghasemi, H., Karimi, A., Ai, J., Rabiee, M., & Rabiee, N. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0027 · Cited by 15

Cardiolipin-Based Lipopolyplex Platform for the Delivery of Diverse Nucleic Acids into Gram-Negative Bacteria

Perche, F., Gall, T. L., Montier, T., Pichon, C., & Malinge, J. (2019) · Pharmaceuticals · doi:10.3390/ph12020081 · Cited by 14

Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines

Twilhaar, M. K. N., Czentner, L., van Nostrum, C. F., Storm, G., & den Haan, J. M. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070954 · Cited by 13

Instigation of the epoch of nanovaccines in cancer immunotherapy

Shah, S., Famta, P., Tiwari, V. K., Kotha, A. K., Kashikar, R., Chougule, M. B., Chung, Y. H., Steinmetz, N. F., Uddin, M. N., Singh, S. B., et al. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1870 · Cited by 14

Stability Criterion for the Assembly of Core–Shell Lipid–Polymer–Nucleic Acid Nanoparticles

Paris, J. L., Gaspar, R., Coelho, F., Beule, P. D., & Silva, B. F. B. (2023) · ACS Nano · doi:10.1021/acsnano.3c07204 · Cited by 13

Personalized mRNA vaccine combined with PD-1 inhibitor therapy in a patient with advanced esophageal squamous cell carcinoma

Wang, B., Peng, X.-B., Li, J., Wang, Y.-R., Chen, L.-P., Wu, M.-H., Zhang, Y.-Y., Wang, W., Feng, D., Tang, S.-H., et al. (2024) · American Journal of Cancer Research · doi:10.62347/nvfb3780 · Cited by 12

CAR T Cell Nanosymbionts: Revealing the Boundless Potential of a New Dyad

Baena, J. C., Pérez, L. M., Toro-Pedroza, A., Kitawaki, T., & Loukanov, A. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313157 · Cited by 13

Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development

Lu, T., Xu, R., Wang, C., Zhao, J., Peng, B., Wang, J., & Zhang, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.853113 · Cited by 12

Piperazine-derived ionizable lipids for enhanced mRNA delivery and cancer immunotherapy

Xu, K. J., Xu, Y., Sun, J., Cheng, X., Lu, C., Chen, W., He, B., & Jiang, T. (2024) · Nano Research · doi:10.1007/s12274-024-6575-8 · Cited by 11

Pharmaceutical strategies for optimized mRNA expression

Shi, Y., Mao, J., Wang, S., Ma, S., Luo, L., & You, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122853 · Cited by 11

An mRNA vaccine induces antimycobacterial immunity by activating DNA damage repair and autophagy

Chen, D., Huang, W., Shen, L., Zhang, J., Pan, Z., Zhang, C., Tang, Y., Zhou, Z., Tao, J., Luo, G., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102402 · Cited by 10

The Immunogenicity of Coxsackievirus A6 (D3a Sub‐Genotype) Virus‐Like Particle and mRNA Vaccines

Lu, H., Xiao, J., Song, J., Song, Y., Li, H., Ren, H., Li, J., Cong, R., Li, H., Fang, Y., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70201 · Cited by 9

A novel lipopolyplex platform for dual mRNA delivery via core- and surface-loading

Gabelmann, A., Mansouri-Ghahnavieh, E., Koch, M., Shinde, P. V., Guzmán, C. A., Loretz, B., & Lehr, C. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113875 · Cited by 9

In Vitro Evaluation of Lipopolyplexes for Gene Transfection: Comparing 2D, 3D and Microdroplet-Enabled Cell Culture

Paris, J. L., Coelho, F., Teixeira, A., Diéguez, L., Silva, B. F. B., & Abalde‐Cela, S. (2020) · Molecules · doi:10.3390/molecules25143277 · Cited by 10

Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations

Phan, T. X., Fan, D., & Melstrom, L. G. (2024) · Current Oncology · doi:10.3390/curroncol31090361 · Cited by 9

GalNAc End‐Capped Poly(β‐amino ester)s with Screened Side Chains for Efficient Gene Delivery

Liu, X., Li, Y., Liu, X., Huang, Y., Wang, F., Li, J., Guo, Y., Zhu, X., Zhu, L., & Zhang, C. (2025) · Small Methods · doi:10.1002/smtd.202401286 · Cited by 8

Precision-engineered mRNA vaccines: antigen design, structural optimization, and programmable delivery for emerging pathogens

Zhang, Y., Li, J., Wang, Z., Kuang, Y., Li, S., & Wang, X. (2025) · Animal Diseases · doi:10.1186/s44149-025-00186-7 · Cited by 9

Poly(beta-amino esters): applications in immunology

Bayraktutan, H., Kopiasz, R. J., Elsherbeny, A., Gurnani, P., & Alexander, C. (2025) · Chemical Science · doi:10.1039/d5sc05951h · Cited by 9

Cellular functions and biomedical applications of circular RNAs

Zhang, Z., & Wang, Z. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024241 · Cited by 9

Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready ‘N Able to Improve Clinical Outcome?

Willemen, Y., Versteven, M., Peeters, M., Berneman, Z. N., & Smits, E. (2020) · Cancers · doi:10.3390/cancers12020299 · Cited by 8

Challenges and opportunities of nanotechnology in cancer immunotherapy

Lee, D., Huntoon, K. M., Jiang, W., & Kim, B. Y. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90949-5.00024-3 · Cited by 8

Macropinocytosis: Both a Target and a Tool for Cancer Therapy

Zhao, M., Zhou, L., Zhai, Y., Sun, A., Shao, G., & Lin, Q. (2025) · Biomolecules · doi:10.3390/biom15070936 · Cited by 8

Current status of vaccine immunotherapy for gastrointestinal cancers

Suzuki, N., Shindo, Y., Nakajima, M., Tsunedomi, R., & Nagano, H. (2023) · Surgery Today · doi:10.1007/s00595-023-02773-y · Cited by 7

Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy

Eskandari, A., Leow, T. C., Rahman, M. B. A., & Oslan, S. N. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01144-3 · Cited by 7

Multicompartmental Lipopolyplex as Vehicle for Antigens and Genes Delivery in Vaccine Formulations

Santos, I. S., Sendra, L., Moret, I., Herrero, M. J., & Aliño, S. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020281 · Cited by 7

Engineering Delivery Technologies for Optimizing mRNA Vaccines

Gu, T., Yan, X., & Liu, S. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00032 · Cited by 7

Biomaterial-enhanced cancer vaccines

Li, S., Wu, J., Li, X., Chen, J., & Wang, C. (2022) · Materials & Design · doi:10.1016/j.matdes.2022.110720 · Cited by 6

Comparison of Current Immunotherapy Approaches and Novel Anti-Cancer Vaccine Modalities for Clinical Application

Meade, E., & Garvey, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178307 · Cited by 5

mRNA vaccines for porcine reproductive and respiratory syndrome: A new paradigm in swine health

Khan, M., Taira, O., Shi, X., Wang, H., & Cai, X. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152950 · Cited by 5

Improved cross-protection and immunity against influenza A virus in mice using a novel mRNA vaccine with optimized design of RNA sequence

Wang, T., Han, R., Hao, Z., Cheng, X., Li, J., Zhai, C., Guo, J., Wang, D., Deng, Y., Zhang, L., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102787 · Cited by 5

Continuous and size-control synthesis of lipopolyplex nanoparticles enabled by controlled micromixing performance for mRNA delivery

Song, S., Liu, Z., Guo, L., Wang, Y., Liu, H., Yang, M., & Chen, G. (2024) · Journal of Flow Chemistry · doi:10.1007/s41981-024-00316-1 · Cited by 5

Role of polyplex charge density in lipopolyplexes

Huang, J., Song, W., Meng, L., Shen, Y., & Zhou, R. (2022) · Nanoscale · doi:10.1039/d1nr07897f · Cited by 5

Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment

Tabasi, H., Mollazadeh, S., Fazeli, E., Abnus, K., Taghdisi, S. M., Ramezani, M., & Alibolandi, M. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04597-5 · Cited by 5

A versatile silica nanoparticle platform for induction of T cell responses – applied for therapeutic vaccination against HPV16 E6/E7-positive tumors in MHC-humanized mice

Kruse, S., Fricke, L. T., Zottnick, S., Schlösser, A., Grabowska, A. K., Feidt, E., Uhl, P., Junglas, E., Förster, J. D., Blersch, J., et al. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2548002 · Cited by 4

Identification of ferroptosis-associated tumor antigens as the potential targets to prevent head and neck squamous cell carcinoma

Zhai, Q., Wang, Z., Tang, H., Hu, S., Chen, M., & Ji, P. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101212 · Cited by 4

Detailed studies on the reduction of aliphatic 3-, 4-, 6-, and 13-oximino esters: Synthesis of novel isomeric amino esters, oximino alcohols, and amino alcohols

Küçük, H. B., Yaşa, H., Yıldız, T., & YUSUFOĞLU, A. S. (2017) · Synthetic Communications · doi:10.1080/00397911.2017.1364768 · Cited by 4

Moderne Konzepte der Nanobiotechnologie für mRNA‐Abgabesysteme

Wang, Y., & Yu, C. (2020) · Angewandte Chemie · doi:10.1002/ange.202003545 · Cited by 4

Synergizing immunity: lipid nanoparticle-mediated mRNA and gene delivery as a next-gen paradigm in cancer immunotherapy

Roy, A. A., Jain, N., Pokale, R., Madhusoodanan, G., Mukharya, A., Farhana, S. A., Rao, B. S. S., Goda, J. S., & Mutalik, S. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126862 · Cited by 4

In virto priming of the STING signaling pathway enhances the maturation and activation of dendritic cells induced by hepatitis B vaccine

Ren, C., Cui, X., Wang, H., Jin, C., Gao, L., Li, Y., Wang, W., Yao, T., Zhang, D., Feng, Y., et al. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.106977 · Cited by 3

Targeting Toll-Like Receptors for the Treatment of Lung Cancer

Rawat, S., Dhaundhiyal, K., Dhramshaktu, I. S., Hussain, M. S., & Gupta, G. (2024) · Springer eBooks · doi:10.1007/978-981-99-7141-1_13 · Cited by 2

Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus

Shan, X., Han, R., Cheng, X., Bing, J., Qi, Z., Sun, S., Wang, T., Chu, Q., Deng, Y., Zhai, D., et al. (2025) · Vaccines · doi:10.3390/vaccines13010093 · Cited by 2

Nanomaterials-enabled mRNA delivery for Cancer immunotherapy

Chen, Y., Liang, S., Peng, Y., Ma, K., Yun, K., Ma, X., Hai, L., Mei, L., Wang, L., & Wang, Z. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216945 · Cited by 2

Matrices Activated with Messenger RNA

Martinez-Campelo, R., & García-Fuentes, M. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14010048 · Cited by 2

Nanoparticles for mRNA-based cancer immunotherapy

Pahwa, R., Sharma, G., Panwar, R., & Mishra, N. (2025) · Advances in immunology · doi:10.1016/bs.ai.2024.10.012 · Cited by 1

Neoantigen mRNA Cancer Vaccines: How Deep Learning Is Advancing Design and Breaking Barriers

Ismail, S., & Barakat, K. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011567 · Cited by 1

Cancer-Immunity Cycle-Based Smart Nucleic Acid Nanodrugs for Potentiated Immunotherapy

Wu, B., Chen, J., Jiang, L., Zhao, Z., Shan, X., Ouyang, C., Jiang, P., Tong, X., Lü, Y., Zhang, J., et al. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00202 · Cited by 1

Structurally-optimised HPV16 E7/E6 mRNA–LPP mediates dose-sparing efficacy via tumour microenvironment reprogramming

Sun, S., Deng, Y., Ren, J., Xiaotian, H., Bing, J., Wang, T., Hao, Z., Tian, H., Zhang, L., & Tan, W. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00412-9 · Cited by 1

Design and characterization of α-linolenic acid-grafted Poly(β-Amino ester) nanocarriers for drug delivery

Kaplan, Ö., Bal, K., Çeli̇k, S. K., Tosun, N. G., & Gök, M. K. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108276 · Cited by 1

Poly(β-amino ester) libraries as multi-objective design platforms: Navigating biological barriers through data-driven optimization

Kaplan, Ö., TUNCEL, N., Bal, K., Çeli̇k, S. K., & Gök, M. K. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108438 · Cited by 1

环形RNA翻译及其在药物研发中的应用

Mao, M., Zhang, Z., Wei, H. Y., & Wang, Z. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0315 · Cited by 1

Module-combinatorial design and screening of multifunctional polymers based on polyaspartic acid for DNA delivery

Xia, Q., Jing, Q., Lu, C., Guo, X., Chen, X., Tang, C., Han, J., Wang, H., Dong, Y., Fang, P., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124350 · Cited by 1

Nanotechnology in Generation and Biomedical Application of Induced Pluripotent Stem Cells

Tang, H., Rui, M., Yu, C., Chu, T., Li, C., Zhan, Z., Cao, H., Li, H., Liu, Z., & Shen, H. (2018) · Nano LIFE · doi:10.1142/s1793984418410027 · Cited by 1

Development of biomaterial porous scaffolds for dendritic cell modulation and mRNA delivery

Chen, R. (2017) · ResearchWorks at the University of Washington (University of Washington)

Designed synthesis of silica based nanocarriers for mRNA delivery

Wang, Y. (2020) · The University of Queensland · doi:10.14264/b28d1e7

The mRNA Technology in Cancer Immunotherapy

Persano, F., Leporatti, S., Persano, S., Guevara, M. L., & Gigli, G. (2022) · Current Nanomaterials · doi:10.2174/2405461507666220131110055

Lipid Nanoparticles to Harness the Therapeutic Potential of mRNA for Cancer Treatment

Guevara, M. L., Persano, F., & Persano, S. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_14

Messenger RNA Nanovaccine in Cancer Immunotherapy

Li, M., & Zhang, H. (2022) · Springer eBooks · doi:10.1007/978-3-031-17831-3_9

mRNA vaccines: a promising solution for incurable diseases

Ge, H., Hei, Y., & Wu, J. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3021657

Nonclinical development of RNA cancer vaccines: proof-of-concept testing, safety study design, and future prospects

Allen, R., & Saeui, C. T. (2023) · Vaccine Insights · doi:10.18609/vac/2023.55

Generation and Characterization of In Vitro Transcribed mRNA

Poveda, C., Chen, Y., & Strych, U. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3770-8_6

Cross Protection and Sustained Immunity Against Influenza a Viruses in Mice Provided by Core-Shell Structured Lipopolyplex Delivered mRNA Vaccine with Optimized Sequences Coding HAstem-Na-Fused AntigensPreprint

Wang, T., Han, R., Hao, Z., Cheng, X., Li, J., Zhai, C., Wang, D., Deng, Y. L., Zhang, L., & Tan, W. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5083848

Nanotechnology for cancer immunotherapy

Zheng, X., Manshian, B. B., & Soenen, S. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00039-4

Advances of mRNA vaccines in genitourinary cancers

Shen, Y.-M., Wan, F., Xu, H., Yu, L., Huang, S., Ye, D., & Dai, B. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189427

Surface-engineered robust hybrid lipid nanocapsules: A next-generation nanoplatform for mRNA delivery

Yadava, S. K., Tripathi, A., Kabilan, M., Champion, J. A., & Cicerone, M. T. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114312 · Cited by 1

Additional file 1 of Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer

Huang, H., Yi, X., Wei, Q., Li, M., Cai, X., Lv, Y., Weng, L., Mao, Y., Fan, W., Zhao, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26566451

Formulation et vectorisation d’un ARN messager vaccinal codant l’antigène Gag du VIH-1 à l’aide de nanoparticules biodégradables de poly(acide lactique)

Coolen, A.-L. (2018) · theses.fr (ABES) · doi:10.70675/ef9de4f6z7bb5z4f28za818ze4ca749ef4c2

Therapeutic cancer vaccines: navigating clinical translation and multimodal synergy

Chu, T.-H., Huynh, T. L., & Phuong, L.-T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1818121

Emerging Trends and Recent Development in the Synthesis of Non-Viral Cationic Systems for Targeted Gene Delivery Applications

Elumalai, S., Jujjuri, L., Das, A., P, V. K., & Maji, S. (2026) · Innovation of Chemistry & Materials for Sustainability · doi:10.63654/icms.2026.03029

A dual-antigen mRNA-lipid polyplex vaccine elicits durable multistage immunity and sterile protection against malaria in mice

Wang, X., Wang, A., Huang, W., Tian, P., Cao, L., Xiao, B., Han, J., Huang, Z., & Jiang, L. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01850-5

Lipid-Based Nanocarriers for Intranasal Delivery: Revolutionizing Neurological Disorder Therapies

Nagapurkar, S., & Chatterjee, B. (2026) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266379726251115040906

Hyperbranched Polylysine‐Based Lipopolyplexes Enable Efficient mRNA Delivery With Long‐Term Storage Stability

Meng, H., Fu, B., Liang, M., 王俏镟, 刘星浦, Li, M., Hu, Q., Duan, Y., & Gao, C. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71571

Abstract LB-205: A lipoplex-based mRNA nanovaccine for cancer immunotherapy

Hongxia, Z., You, X., Xiaojuan, W., Wang, Z., Xu, F., Wu, J., & Xia, X. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-lb-205 · Cited by 6

A Structurally Stabilized Lipopolymer Nanoplatform Targeting Pan‐Tissue Antigen‐Presenting Cells Enables Durable in situ mRNA Cancer Immunotherapy

Zeng, L. L., Shen, Q., Wei, L., Jiang, M. J., Liao, J., Ren, Y., Zhang, Z., Fan, H., Cao, X., Chen, J., et al. (2026) · Advanced Materials · doi:10.1002/adma.202520594 · Cited by 3

Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration

Guevara, M. L., Jilesen, Z., Stojdl, D., & Persano, S. (2019) · ACS Omega · doi:10.1021/acsomega.9b00489 · Cited by 58

Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells

Moignic, A. L., Malard, V., Benvegnu, T. J., Lemiègre, L., Berchel, M., Jaffrès, P., Baillou, C., Guillot‐Delost, M., Macedo, R., Rochefort, J., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.035 · Cited by 129

Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety

Van der Jeught, K., De Koker, S., Bialkowski, L., Heirman, C., Tjok Joe, P., Perche, F., Maenhout, S., Bevers, S., Broos, K., Deswarte, K., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00966 · Cited by 139